Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 6601-6650 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05794230
Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa
PHASE3Active, not recruiting
1,528 participants
Started: Mar 27, 2023 · Completed: Dec 2, 2025
2 conditions1 sponsor15 locations
NCT05714098
Gerofit Exercise Intervention for Older Adults With Sickle Cell Disease (SICKLE-FIT Study)
NAActive, not recruiting
30 participants
Started: Mar 27, 2023 · Completed: Aug 30, 2025
1 condition2 sponsors1 location
NCT05522140
Testing a Nature-based Socila Intevention on Loneliness: the RECETAS-PRG Trial
NAActive, not recruiting
316 participants
Started: Mar 27, 2023 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT06776055
Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women
N/AActive, not recruiting
5,372 participants
Started: Mar 27, 2023 · Completed: Jun 30, 2026
5 conditions2 sponsors9 locations
NCT05630183
A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer
PHASE2Active, not recruiting
81 participants
Started: Mar 27, 2023 · Completed: Dec 5, 2025
1 condition1 sponsor36 locations
NCT05601973
Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI
PHASE2Active, not recruiting
60 participants
Started: Mar 27, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors18 locations
NCT05872555
Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective Study
N/AActive, not recruiting
22,777 participants
Started: Mar 26, 2023 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05786586
650nm Low-level Red-light for Myopia Control and Prevention in Children
NAActive, not recruiting
572 participants
Started: Mar 26, 2023 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT06495242
Direct Pulp Capping Compared to Partial Pulpotomy in Carious Pulp Exposures
NAActive, not recruiting
120 participants
Started: Mar 25, 2023 · Completed: Dec 2, 2026
1 condition2 sponsors1 location
NCT05242965
A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
5 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations
NCT05894096
Air Cold Atmospheric Pressure Plasma Treatment for Acceleration of Venous Ulcer Healing
NAActive, not recruiting
68 participants
Started: Mar 24, 2023 · Completed: Mar 30, 2025
1 condition4 sponsors5 locations
NCT05715216
EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer
PHASE2Active, not recruiting
20 participants
Started: Mar 24, 2023 · Completed: Feb 8, 2026
1 condition2 sponsors1 location
NCT05501873
Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System
N/AActive, not recruiting
1,173 participants
Started: Mar 24, 2023 · Completed: Aug 15, 2027
1 condition1 sponsor48 locations
NCT05787652
Adults Regulating Their Weight Everyday With Mobile Internet Support
NAActive, not recruiting
1,294 participants
Started: Mar 24, 2023 · Completed: Mar 23, 2025
1 condition2 sponsors1 location
NCT05736679
EaveTubes for Vector Control
NAActive, not recruiting
1,870 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05781321
Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study
PHASE2Active, not recruiting
170 participants
Started: Mar 23, 2023 · Completed: Jul 2, 2028
1 condition1 sponsor8 locations
NCT05689567
Focus-out Glasses on Emmetropization in Chinese Children
NAActive, not recruiting
160 participants
Started: Mar 23, 2023 · Completed: Mar 31, 2025
3 conditions1 sponsor1 location
NCT05805826
To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults
PHASE1/PHASE2Active, not recruiting
689 participants
Started: Mar 23, 2023 · Completed: Aug 28, 2028
1 condition1 sponsor25 locations
NCT05642325
Vamikibart in Participants With Uveitic Macular Edema
PHASE3Active, not recruiting
256 participants
Started: Mar 23, 2023 · Completed: Dec 14, 2025
1 condition1 sponsor94 locations
NCT05714202
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
PHASE3Active, not recruiting
1,135 participants
Started: Mar 23, 2023 · Completed: Sep 18, 2029
1 condition1 sponsor240 locations
NCT06047964
SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis
NAActive, not recruiting
281 participants
Started: Mar 23, 2023 · Completed: Jan 23, 2025
2 conditions1 sponsor9 locations
NCT05323955
Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib
PHASE2Active, not recruiting
48 participants
Started: Mar 23, 2023 · Completed: Jul 31, 2026
3 conditions2 sponsors8 locations
NCT05887297
Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence
NAActive, not recruiting
35 participants
Started: Mar 23, 2023 · Completed: May 23, 2024
5 conditions1 sponsor1 location
NCT05413811
Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV
NAActive, not recruiting
180 participants
Started: Mar 22, 2023 · Completed: Aug 24, 2025
5 conditions2 sponsors1 location
NCT05835362
Improving the Outcomes of Adolescents With ADHD Via a Pre-visit Question Prompt List/Video Intervention
NAActive, not recruiting
140 participants
Started: Mar 22, 2023 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT05673577
Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients
PHASE2Active, not recruiting
40 participants
Started: Mar 22, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05768958
Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the Context of Meal and Exercise Timing
NAActive, not recruiting
58 participants
Started: Mar 22, 2023 · Completed: Jul 31, 2026
2 conditions3 sponsors1 location
NCT05669482
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
PHASE1/PHASE2Active, not recruiting
40 participants
Started: Mar 22, 2023 · Completed: Aug 31, 2027
5 conditions1 sponsor12 locations
NCT05767034
Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)
PHASE3Active, not recruiting
381 participants
Started: Mar 22, 2023 · Completed: Feb 17, 2026
1 condition1 sponsor134 locations
NCT07076784
Topical Icariin on Acne and Acne Scars
NAActive, not recruiting
25 participants
Started: Mar 21, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05646836
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma
PHASE1Active, not recruiting
90 participants
Started: Mar 21, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor13 locations
NCT05992558
Longitudinal Multimarker Risk Models for Very Elderly Patients With Heart Failure and Preserved Ejection Fraction
N/AActive, not recruiting
184 participants
Started: Mar 21, 2023 · Completed: Jan 31, 2026
1 condition3 sponsors1 location
NCT05621096
Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
PHASE1Active, not recruiting
33 participants
Started: Mar 21, 2023 · Completed: Sep 30, 2027
7 conditions2 sponsors1 location
NCT05641103
"PREDIGA 2: Spanish Acronym of Educational and Diagnostic Project for Gaucher and ASMD"
N/AActive, not recruiting
122 participants
Started: Mar 21, 2023 · Completed: Dec 31, 2025
5 conditions1 sponsor14 locations
NCT05891847
Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia
N/AActive, not recruiting
150 participants
Started: Mar 21, 2023 · Completed: Mar 20, 2026
1 condition1 sponsor5 locations
NCT05846932
Preliminary Efficacy of Occupational Therapy Integrating Horses on Self-regulation in Youth With Autism
NAActive, not recruiting
73 participants
Started: Mar 21, 2023 · Completed: Nov 1, 2025
1 condition3 sponsors1 location
NCT02987257
NATIENS: Optimal Management and Mechanisms of SJS/TEN
PHASE3Active, not recruiting
2 participants
Started: Mar 21, 2023 · Completed: Oct 31, 2025
2 conditions3 sponsors14 locations
NCT05653037
A Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD4059 in Healthy Subjects
PHASE1Active, not recruiting
32 participants
Started: Mar 21, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06540950
Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer
PHASE2Active, not recruiting
47 participants
Started: Mar 20, 2023 · Completed: Jun 10, 2026
1 condition1 sponsor1 location
NCT06092190
Effect of Spasticity on Tibial Nerve Entrapment
N/AActive, not recruiting
100 participants
Started: Mar 20, 2023 · Completed: Oct 20, 2023
2 conditions1 sponsor1 location
NCT05750862
Accuracy of Topography Guided Automatic Marking of the Intraocular Lens (IOL) -Axis
NAActive, not recruiting
30 participants
Started: Mar 20, 2023 · Completed: Jun 1, 2024
2 conditions1 sponsor1 location
NCT05690503
Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial
PHASE2Active, not recruiting
12 participants
Started: Mar 20, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05192863
A Study of Vedolizumab in Adults With Crohn's Disease (CD)
N/AActive, not recruiting
72 participants
Started: Mar 20, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor10 locations
NCT06798727
Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control
PHASE2Active, not recruiting
84 participants
Started: Mar 20, 2023 · Completed: Nov 30, 2027
1 condition1 sponsor5 locations
NCT05342155
Patient- Generated Health Data to Predict Childhood Cancer Survivorship Outcomes
N/AActive, not recruiting
602 participants
Started: Mar 20, 2023 · Completed: Jun 20, 2028
2 conditions2 sponsors1 location
NCT04832685
Neuromodulation of Mind-Wandering in Depression
NAActive, not recruiting
80 participants
Started: Mar 20, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05798156
Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP
PHASE2Active, not recruiting
125 participants
Started: Mar 20, 2023 · Completed: Sep 30, 2028
1 condition7 sponsors30 locations
NCT04485949
A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
PHASE2Active, not recruiting
93 participants
Started: Mar 20, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor23 locations
NCT06762301
The Effect of Sexual Education-Counseling According to PLISSIT Model of Couples' Sexual Functions During Pregnancy and Postpartum
NAActive, not recruiting
70 participants
Started: Mar 20, 2023 · Completed: Jun 30, 2025
5 conditions2 sponsors1 location
NCT06765395
Explore Association Models Between Environmental Hormones andBreast Cancer
N/AActive, not recruiting
687 participants
Started: Mar 20, 2023 · Completed: Mar 31, 2025
2 conditions1 sponsor1 location